Single GlcNAc serves as a critical intermediate in the synthesis of anti-inflammatory and joint-health pharmaceuticals. Our high-purity production supports the development of next-generation glycan-based drugs and prodrugs for metabolic disorders.
The biological significance of N-acetylglucosamine (GlcNAc) extends far beyond its role as a simple monosaccharide building block. As a fundamental unit of chitin, peptidoglycan, and N-linked glycans, GlcNAc is a critical signaling molecule and a structural determinant in cellular physiology. At CD BioGlyco, we recognize that high-purity, structurally verified single GlcNAc and its functionalized derivatives are indispensable for modern glycobiology research, pharmaceutical formulation, and diagnostic development. Our single-GlcNAc production service is a specialized component of our natural glycan production service. We leverage advanced metabolic engineering and enzymatic synthesis to bypass the limitations of traditional chemical extraction, such as low yield and environmental toxicity. By utilizing optimized microbial "chassis," we provide a sustainable and scalable pipeline for producing ultra-pure GlcNAc and specialized analogs, ensuring that researchers have access to the highest quality substrates for O-GlcNAcylation studies, metabolic labeling, and preclinical research.
Metabolic Pathway Engineering
We utilize genome editing to optimize microbial hosts, such as Escherichia coli or Bacillus subtilis. By overexpressing key genes like glucosamine-6-phosphate synthase (glmS) and N-acetylglucosamine-6-phosphate deacetylase (nagA) deletions, we redirect carbon flux specifically toward GlcNAc accumulation while minimizing byproduct formation.
Enzymatic Bioconversion Systems
For high-value GlcNAc derivatives, we employ cell-free multienzyme systems. These systems utilize recombinant glycosyltransferases and kinases to catalyze the site-specific modification of GlcNAc, ensuring 100% stereoselectivity and eliminating the need for complex protection/deprotection steps common in organic chemistry.
High-Performance Purification and Analytics
We utilize simulated moving bed (SMB) chromatography and ultrafiltration to isolate GlcNAc from fermentation broths. Final products are verified using nuclear magnetic resonance (NMR) spectroscopy and high-performance liquid chromatography-mass spectrometry (HPLC-MS) to ensure chemical identity and absolute purity.
At CD BioGlyco, our single GlcNAc production service is designed to address the diverse needs of the global scientific community. This service encompasses the entire development lifecycle, from the initial design of the production chassis to the final purification of the target molecule. As a subset of our natural glycan production service, we specialize in creating biological systems that mimic the natural biosynthetic pathways of GlcNAc but operate at industrial efficiencies.
The production of GlcNAc-related substances often involves complex metabolic intermediates. Our expertise allows us to provide custom development services for not only standard GlcNAc but also modified versions, such as N-azidoacetylglucosamine (GlcNAz) for click chemistry applications or isotopically labeled GlcNAc for metabolic flux analysis. We implement these services through a modular approach. For clients requiring bulk quantities for nutraceutical or cosmeceutical applications, we utilize large-scale fermentation platforms optimized for high-density cell growth. Conversely, for clients focused on drug discovery, we offer high-throughput micro-scale synthesis of rare GlcNAc analogs.
Our implementation strategy involves a deep analysis of the target molecule's biosynthetic route. If a client requires a specific GlcNAc derivative, we select the most appropriate enzymatic tools and expression hosts. We handle the optimization of fermentation parameters, such as pH, temperature, and dissolved oxygen, to maximize the specific productivity of the chassis. Furthermore, CD BioGlyco provides characterization data, ensuring that the produced GlcNAc meets the stringent requirements of downstream applications like glycopeptide synthesis or the development of O-GlcNAc transferase (OGT) inhibitors. By integrating our chassis development capabilities with our glycan production expertise, we offer a seamless transition from bench-scale concept to commercial-scale reality.
Every project begins with a detailed assessment of the client's requirements, including the desired scale, purity levels, and specific GlcNAc modifications. Our specialists design the optimal metabolic pathway or enzymatic cascade.
Using our proprietary microbial engineering platform, we modify host organisms to enhance GlcNAc biosynthesis. This involves the insertion of robust promoters and the deletion of competitive metabolic pathways to ensure maximum yield.
The engineered strains are cultivated in bioreactors where we perform real-time monitoring. We optimize the feeding strategy and environmental conditions to achieve the highest possible titer of single GlcNAc.
Following fermentation, the broth undergoes a series of separation steps, including centrifugation, membrane filtration, and ion-exchange chromatography, to remove cellular debris and impurities.
Each batch of GlcNAc is subjected to rigorous QC. We utilize HPLC-MS and NMR to confirm structural integrity and ensure the absence of endotoxins or heavy metals, meeting international safety standards.
The final product is lyophilized for stability and shipped with a certificate of analysis (CoA). We provide full technical support to assist in the integration of our GlcNAc into the client's specific workflow.
Single GlcNAc serves as a critical intermediate in the synthesis of anti-inflammatory and joint-health pharmaceuticals. Our high-purity production supports the development of next-generation glycan-based drugs and prodrugs for metabolic disorders.
In epigenetics and signal transduction, the modification of proteins with a single GlcNAc residue is vital. We provide specialized GlcNAc substrates and chemical reporters to study O-GlcNAc transferase activity in cancer and neurodegeneration.
Our service enables the production of functionalized GlcNAc for use in diagnostic assays. These molecules are essential for labeling cell-surface glycans, allowing for the visual detection of pathogen-host interactions and biomarker identification.
Beyond the lab, high-quality GlcNAc is a key ingredient in premium skin-care products and dietary supplements. Our scalable production ensures a consistent supply of bioavailable GlcNAc for health and wellness applications.
CD BioGlyco utilizes advanced chromatographic techniques to deliver GlcNAc with purity exceeding 98%. Our stabilization processes ensure that the product maintains its chemical integrity during shipping and long-term storage.
We don't just provide off-the-shelf products. Our team synthesizes a wide range of GlcNAc analogs, including fluorinated, azido-modified, or isotopically labeled variants, specifically designed for your unique research objectives.
Our engineered microbial hosts are designed for seamless scale-up. Whether you need milligram quantities for pilot studies or multi-kilogram batches for industrial use, our platform maintains consistent quality across all scales.
Our team consists of PhD-level scientists with decades of experience in carbohydrate chemistry and metabolic engineering. We provide in-depth consultation to help you choose the right GlcNAc derivative for your application.
"The Single GlcNAc provided by CD BioGlyco was of exceptional quality. We utilized their azido-modified GlcNAc for metabolic labeling in our neurobiology studies, and the signal-to-noise ratio was better than what we achieved with other suppliers. Their technical team's depth of knowledge was instrumental in our experimental design."
– C.R., Principal Investigator, Molecular Biology Research Institute.
"As a startup focusing on glycan-based therapeutics, we needed a reliable partner for scalable GlcNAc production. CD BioGlyco delivered on both quality and timeline. Their ability to scale from milligram to gram quantities seamlessly saved us months of development time. Highly recommended for any organization requiring high-purity glycans."
– Z.T., Director of CMC, Biotechnology Firm.
"We have been sourcing isotopically labeled GlcNAc from CD BioGlyco for over two years. The consistency between batches is remarkable, which is crucial for our quantitative mass spectrometry workflows. Their customer service is responsive and technically proficient."
– W.T., Senior Scientist, Glycomics Core Facility.
CD BioGlyco stands at the forefront of the glycobiology industry, providing a sophisticated single GlcNAc production service that merges metabolic engineering with industrial-scale biomanufacturing. By leveraging our specialized chassis development and purification expertise, we deliver high-purity, custom-modified GlcNAc that empowers researchers to push the boundaries of drug discovery, diagnostics, and fundamental cell biology. Please feel free to to elevate your glycobiology research with precision-engineered GlcNAc.